Stock Market Reviews

Read and share opinions on AMPH (Amphastar Pharmaceuticals, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock

Latest News

• Why Amphastar Pharmaceuticals (AMPH) Is Up 8.4% After Strong Q3 Revenue and Key FDA Approvals
  Nov 15, 2025
• 5 Must-Read Analyst Questions From Amphastar Pharmaceuticals’s Q3 Earnings Call
  Nov 13, 2025
• Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today
  Nov 12, 2025
• Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
  Nov 12, 2025
• Generic Pharmaceuticals Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Simply the Best
  Nov 12, 2025
• Why Are Amphastar Pharmaceuticals (AMPH) Shares Soaring Today
  Nov 10, 2025
• AMPH Q3 Deep Dive: Pipeline Expansion and Core Product Growth Offset Margin Pressures
  Nov 10, 2025
• A Fresh Look at Amphastar Pharmaceuticals (AMPH) Valuation After Recent Share Price Decline
  Nov 9, 2025
• Amphastar Pharmaceuticals Inc (AMPH) Q3 2025 Earnings Call Highlights: Strong Core Product ...
  Nov 8, 2025
• Why Amphastar Pharmaceuticals (AMPH) Stock Is Up Today
  Nov 7, 2025
• Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings
  Nov 6, 2025
• Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Top Estimates
  Nov 6, 2025
• Amphastar Pharmaceuticals (NASDAQ:AMPH) Delivers Strong Q3 Numbers
  Nov 6, 2025
• Amphastar: Q3 Earnings Snapshot
  Nov 6, 2025
• Amphastar Pharmaceuticals (AMPH) To Report Earnings Tomorrow: Here Is What To Expect
  Nov 5, 2025
• How Amphastar’s New BAQSIMI Distribution Pact in Greater China Could Impact AMPH Investors
  Oct 31, 2025
• Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
  Oct 30, 2025